Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Zhong Xi Yi Jie He Xue Bao ; 5(5): 526-30, 2007 Sep.
Article in Chinese | MEDLINE | ID: mdl-17854544

ABSTRACT

OBJECTIVE: To study the effects of Wenyang Chubi Decoction (WYCBD), a compound traditional Chinese herbal medicine, on connective tissue growth factor (CTGF) and collagen-I (COL-I) in a mouse model of scleroderma. METHODS: Scleroderma was induced in BALB/c mice by daily local injection of bleomycin for three weeks and the mice were randomly divided into untreated, WYCBD-treated and normal saline (NS) treated groups, with another group of BALB/c mice as normal control. WYCBD and NS were given orally for one month respectively. Histopathology in the skin and lungs of the mice were examined. The CTGF and COL-I expressions in the skin or skin lesions were detected by immunohistochemical Elivision assay. RESULTS: The expression levels of CTGF and COL-I in the untreated group were significantly higher than those in the normal control group (P<0.05). Compared with the NS-treated group, the WYCBD-treated group had significant improvement in the skin and lung histopathology and remarkably decreased expression levels of CTGF and COL-I (P<0.05). CONCLUSION: Scleroderma mice showed high expressions of CTGF and COL-I in the skin. WYCBD had the effects of decreasing the CTGF and COL-I expressions and improving the skin fibrosis.


Subject(s)
Collagen Type I/metabolism , Connective Tissue Growth Factor/metabolism , Drugs, Chinese Herbal/therapeutic use , Phytotherapy , Scleroderma, Systemic/drug therapy , Animals , Bleomycin , Female , Mice , Mice, Inbred BALB C , Random Allocation , Scleroderma, Systemic/chemically induced , Scleroderma, Systemic/metabolism , Skin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...